These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1153509

  • 1. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs.
    Buczko W, Moniuszko-Jakoniuk J.
    Pharmacology; 1975; 13(3):252-9. PubMed ID: 1153509
    [Abstract] [Full Text] [Related]

  • 2. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W.
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system activity of 1-(3-methoxypropylamino)-2-hydroxy-2-(1,4-benzodioxan-2-yl)-ethane hydrochloride.
    Cestari A, Babbini M, De Marchi F, Graziani G.
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):167-80. PubMed ID: 6069043
    [No Abstract] [Full Text] [Related]

  • 4. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J, Buczko W.
    Pol J Pharmacol Pharm; 1977 Jan; 29(3):313-9. PubMed ID: 560684
    [Abstract] [Full Text] [Related]

  • 5. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system.
    Wiśniewski K, Buczko W, Moniuszko-Jakoniuk J.
    Acta Neurobiol Exp (Wars); 1975 Jan; 35(3):275-83. PubMed ID: 126007
    [Abstract] [Full Text] [Related]

  • 6. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
    Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1979 Jan; 31(5):473-80. PubMed ID: 575732
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of psychoactive drugs on cat behavior.
    Norton S.
    Ann N Y Acad Sci; 1969 Jul 30; 159(3):915-27. PubMed ID: 5260307
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of increased fibrinolytic activity of rats blood on the action of some centrally acting drugs.
    Lukaszyk A, Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1982 Jul 30; 34(1-3):93-100. PubMed ID: 7167425
    [Abstract] [Full Text] [Related]

  • 12. Studies of the spontaneous movement of animals by the hole cross test; effect of 2-dimethyl-aminoethanol and its acyl esters on the central nervous system.
    Takagi K, Watanabe M, Saito H.
    Jpn J Pharmacol; 1971 Dec 30; 21(6):797-810. PubMed ID: 5316865
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products.
    Arnesen H, Godal HC.
    Scand J Haematol; 1973 Dec 30; 10(3):232-40. PubMed ID: 4797626
    [No Abstract] [Full Text] [Related]

  • 14. The role of peptides in the central nervous system function.
    Wiśniewski K.
    Pol J Pharmacol Pharm; 1976 Dec 30; 28(6):647-54. PubMed ID: 189293
    [Abstract] [Full Text] [Related]

  • 15. Influence of fibrinogen degradation products (FDP) on the central action of acetylcholine.
    Zadrozna B, Buczko W.
    Pol J Pharmacol Pharm; 1976 Dec 30; 28(6):679-84. PubMed ID: 1012988
    [Abstract] [Full Text] [Related]

  • 16. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I, Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1979 Dec 30; 31(4):365-72. PubMed ID: 574959
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J, Hano J, Sypniewska M, Czarnecki R, Chojnacka-Wójcik E, Harasiewicz A.
    Pol J Pharmacol Pharm; 1973 Dec 30; 25(1):1-16. PubMed ID: 4798097
    [No Abstract] [Full Text] [Related]

  • 18. Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino(2',1':6,1)pyrido(3,4-b)indoles. A new class of central nervous system depressants.
    Saxena AK, Jain PC, Anand N.
    J Med Chem; 1973 May 30; 16(5):560-4. PubMed ID: 4718475
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of psychotropic substances on electroencephalographic indices of the inhibitory function of the caudate nucleus].
    Tolpyshev BA.
    Farmakol Toksikol; 1975 May 30; 38(1):15-7. PubMed ID: 1112387
    [No Abstract] [Full Text] [Related]

  • 20. [Modification of central mechanisms of action by anticholinergics].
    Haas H, Jantos W.
    Arzneimittelforschung; 1969 Jan 30; 19(1):54-62. PubMed ID: 5819363
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.